AcelRx Pharmaceuticals' ARX-04 Final Stage Study Meets Primary Endpoint
August 15, 2016 at 08:11 AM EDT
AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) disclosed top line results of its ARX-04 final stage study, which met its primary ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.